SG10201704166RA - Improving resistance to skeletal muscle fatigue - Google Patents
Improving resistance to skeletal muscle fatigueInfo
- Publication number
- SG10201704166RA SG10201704166RA SG10201704166RA SG10201704166RA SG10201704166RA SG 10201704166R A SG10201704166R A SG 10201704166RA SG 10201704166R A SG10201704166R A SG 10201704166RA SG 10201704166R A SG10201704166R A SG 10201704166RA SG 10201704166R A SG10201704166R A SG 10201704166RA
- Authority
- SG
- Singapore
- Prior art keywords
- skeletal muscle
- muscle fatigue
- improving resistance
- improving
- resistance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261623003P | 2012-04-11 | 2012-04-11 | |
US201261646842P | 2012-05-14 | 2012-05-14 | |
US201261693061P | 2012-08-24 | 2012-08-24 | |
US201261735809P | 2012-12-11 | 2012-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201704166RA true SG10201704166RA (en) | 2017-06-29 |
Family
ID=49328282
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201406359TA SG11201406359TA (en) | 2012-04-11 | 2013-04-11 | Improving resistance to skeletal muscle fatigue |
SG10201704166RA SG10201704166RA (en) | 2012-04-11 | 2013-04-11 | Improving resistance to skeletal muscle fatigue |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201406359TA SG11201406359TA (en) | 2012-04-11 | 2013-04-11 | Improving resistance to skeletal muscle fatigue |
Country Status (15)
Country | Link |
---|---|
US (2) | US20150250784A1 (ja) |
EP (1) | EP2836590A4 (ja) |
JP (2) | JP6352244B2 (ja) |
KR (1) | KR102163931B1 (ja) |
CN (2) | CN104395458A (ja) |
AU (3) | AU2013245917A1 (ja) |
BR (1) | BR112014025251B1 (ja) |
CA (1) | CA2869675C (ja) |
EA (1) | EA032480B1 (ja) |
HK (1) | HK1206389A1 (ja) |
IL (2) | IL234886A (ja) |
MX (1) | MX2014012179A (ja) |
PH (1) | PH12014502286A1 (ja) |
SG (2) | SG11201406359TA (ja) |
WO (1) | WO2013155262A2 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8299248B2 (en) | 2006-08-02 | 2012-10-30 | Cytokinetics, Incorporated | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use |
WO2011133920A1 (en) | 2010-04-23 | 2011-10-27 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
EA028060B1 (ru) | 2011-07-13 | 2017-10-31 | Сайтокинетикс, Инк. | Комбинированная терапия бокового амиотрофического склероза |
KR20150131224A (ko) | 2013-03-14 | 2015-11-24 | 노파르티스 아게 | 돌연변이 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온 |
RS63018B1 (sr) * | 2014-04-29 | 2022-04-29 | Cytokinetics Inc | Metode za smanjenje opadanja vitalnog kapaciteta |
BR112017003745A2 (pt) | 2014-08-29 | 2017-12-05 | Tes Pharma S R L | inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico |
WO2016039367A1 (ja) * | 2014-09-09 | 2016-03-17 | アステラス製薬株式会社 | 尿失禁予防用及び/又は治療用新規医薬組成物 |
LT3413892T (lt) | 2016-02-12 | 2022-06-10 | Cytokinetics, Incorporated | Tetrahidroizochinolino dariniai |
MA45656A (fr) | 2016-07-14 | 2021-03-24 | Pfizer | Nouveaux pyrimidine carboxamides utilisées comme inhibiteurs de l'enzyme vanin-1 |
WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
CA3176635A1 (en) | 2020-11-06 | 2022-05-12 | Cytokinetics, Inc. | Bicyclic 1,4-diazepanones and therapeutic uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005139081A (ja) * | 2003-11-04 | 2005-06-02 | Takada Seiyaku Kk | ビントペロール含有製剤 |
US8227603B2 (en) * | 2006-08-01 | 2012-07-24 | Cytokinetics, Inc. | Modulating skeletal muscle |
SI2583970T1 (sl) * | 2006-08-02 | 2016-03-31 | Cytokinetics, Inc. | Določene kemijske enote, sestavki in postopki, ki obsegajo imidazopirimidine |
US8299248B2 (en) * | 2006-08-02 | 2012-10-30 | Cytokinetics, Incorporated | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use |
CA2713864A1 (en) * | 2008-02-04 | 2009-08-13 | Cytokinetics, Incorporated | Certain chemical entities, compositions and methods |
AR081331A1 (es) * | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
AU2013243671B2 (en) * | 2012-04-02 | 2017-09-21 | Cytokinetics, Inc. | Methods for improving diaphragm function |
-
2013
- 2013-04-11 SG SG11201406359TA patent/SG11201406359TA/en unknown
- 2013-04-11 CN CN201380019567.7A patent/CN104395458A/zh active Pending
- 2013-04-11 KR KR1020147028128A patent/KR102163931B1/ko active IP Right Grant
- 2013-04-11 CA CA2869675A patent/CA2869675C/en active Active
- 2013-04-11 CN CN202010369880.5A patent/CN111840294A/zh active Pending
- 2013-04-11 MX MX2014012179A patent/MX2014012179A/es unknown
- 2013-04-11 EP EP13775275.4A patent/EP2836590A4/en not_active Ceased
- 2013-04-11 WO PCT/US2013/036114 patent/WO2013155262A2/en active Application Filing
- 2013-04-11 JP JP2015505896A patent/JP6352244B2/ja active Active
- 2013-04-11 EA EA201491666A patent/EA032480B1/ru not_active IP Right Cessation
- 2013-04-11 AU AU2013245917A patent/AU2013245917A1/en not_active Abandoned
- 2013-04-11 SG SG10201704166RA patent/SG10201704166RA/en unknown
- 2013-04-11 US US14/391,087 patent/US20150250784A1/en not_active Abandoned
- 2013-04-11 BR BR112014025251-3A patent/BR112014025251B1/pt active IP Right Grant
-
2014
- 2014-09-29 IL IL234886A patent/IL234886A/en active IP Right Grant
- 2014-10-10 PH PH12014502286A patent/PH12014502286A1/en unknown
-
2015
- 2015-07-22 HK HK15106995.5A patent/HK1206389A1/xx unknown
-
2017
- 2017-02-06 IL IL250473A patent/IL250473A0/en unknown
- 2017-12-28 JP JP2017253312A patent/JP6535727B2/ja active Active
-
2018
- 2018-02-08 AU AU2018200930A patent/AU2018200930A1/en not_active Abandoned
- 2018-11-30 US US16/206,747 patent/US20190167676A1/en not_active Abandoned
-
2019
- 2019-11-22 AU AU2019268177A patent/AU2019268177A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20150250784A1 (en) | 2015-09-10 |
JP6535727B2 (ja) | 2019-06-26 |
EA032480B1 (ru) | 2019-06-28 |
EP2836590A2 (en) | 2015-02-18 |
BR112014025251B1 (pt) | 2021-03-02 |
PH12014502286B1 (en) | 2014-12-15 |
IL234886A (en) | 2017-02-28 |
US20190167676A1 (en) | 2019-06-06 |
WO2013155262A2 (en) | 2013-10-17 |
EP2836590A4 (en) | 2016-04-13 |
PH12014502286A1 (en) | 2014-12-15 |
CN104395458A (zh) | 2015-03-04 |
MX2014012179A (es) | 2015-07-14 |
JP2018048209A (ja) | 2018-03-29 |
KR102163931B1 (ko) | 2020-10-12 |
AU2019268177A1 (en) | 2019-12-12 |
CA2869675C (en) | 2022-06-14 |
CA2869675A1 (en) | 2013-10-17 |
HK1206389A1 (en) | 2016-01-08 |
SG11201406359TA (en) | 2014-11-27 |
AU2018200930A1 (en) | 2018-03-01 |
CN111840294A (zh) | 2020-10-30 |
AU2013245917A1 (en) | 2014-10-23 |
KR20160046694A (ko) | 2016-04-29 |
WO2013155262A3 (en) | 2013-12-27 |
EA201491666A1 (ru) | 2015-03-31 |
JP2015516392A (ja) | 2015-06-11 |
JP6352244B2 (ja) | 2018-07-04 |
IL250473A0 (en) | 2017-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1206389A1 (en) | Methods for improving resistance to skeletal muscle fatigue | |
EP2906114A4 (en) | PREDICTION OF THE RESPONSE TO A STIMULUS | |
IL226745A0 (en) | Simulates a physical heart | |
EP2842436A4 (en) | TRAINING CLOTHING WITH STEP | |
HK1205031A1 (en) | Exercise mat | |
EP2742938A4 (en) | AMINO-ACIDIC COMPOSITION FOR IMPROVED RECOVERY OF MUSCULAR TEMPERING | |
SG11201501802VA (en) | Implement for training facial muscle | |
ZA201504845B (en) | Trampolines | |
HUE043603T2 (hu) | Sejtmentesített izommátrix | |
GB201316224D0 (en) | Improvements in or relating to stairlifts | |
GB201212069D0 (en) | Predicting resistance to disease | |
EP2894215A4 (en) | FAT COMPOSITION | |
PL2684481T3 (pl) | Sportowy lub fitnessowy kijek treningowy | |
AP2015008378A0 (en) | Improvements relating to buoyancy-supported risers | |
GB201215007D0 (en) | Improvements in or relating to luminaires | |
GB201211746D0 (en) | Improvements in or relating to exercise devices | |
GB2510810B (en) | Improvements in or relating to stairlifts | |
GB2503199B (en) | Improvements in or relating to stairlifts | |
GB2508793B (en) | Improvements in or relating to hardware | |
GB2499408B (en) | Improvements in or relating to stairlifts | |
GB201203631D0 (en) | Exercise bar | |
ZA201406595B (en) | Sports grips | |
GB201220690D0 (en) | Improvements relating to pasteurisation | |
GB201221194D0 (en) | hand exerciser | |
GB2499409B (en) | Improvements in or relating to stairlifts |